Vivanza Biosciences Share Price
14 Aug, 2026 4:01 PM (IST)
Vivanza Biosciences Performance
- Today's Low
- ₹2
- Today's High
- ₹2
- 52 Week Low
- ₹2
- 52 Week High
- ₹3
- Open Price₹2
- Previous Close₹2
- Volume28,095
- 50 DMA₹1.90
- 100 DMA₹1.90
- 200 DMA₹2.00
Vivanza Biosciences Chart
Investment Returns
- Over 1 Month + 1.06%
- Over 3 Month + 2.7%
- Over 6 Month -11.63%
- Over 1 Year -7.32%
Smart Investing Starts Here Start SIP with Vivanza Biosciences for Steady Growth!
Vivanza Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 16.7
- PEG Ratio
- 0.1
- Market Cap Cr
- 8
- P/B Ratio
- 1.7
- Average True Range
- 0.1
- EPS
- 0.1
- Dividend Yield
- 0
- MACD Signal
- -
- RSI
- 51.63
- MFI
- 49.65
Latest Stock News Updates
Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 ,inter alia, to consider and approve 1) To consider and approve the Director''s Report and Secretarial Audit Report along with annexure for the Financial Year 2025-26; 2) To consider and approve the convening of the 44th (AGM) of the Members of the Company and to approve the draft Notice of the 44th AGM of the Company; 3) To appoint Mr. Chintan K. Patel, Practicing Company Secretary (Mem No: A31987, COP: 11959) as Scrutinizer for the the 44th AGM; 4) Fixing of September 04, 2026 as the "Cut-Off Date" for 44th Annual General Meeting of the Company. 5) To consider and approve the proposal for adoption of the Memorandum of Association and Articles of Association of the Company in conformity with the provisions of the Companies Act, 2013, and to recommend the same for approval of the Members at the ensuing Annual General Meeting. 6. To consider and approve the proposal for obtaining approval of the Members for the proposed transaction under Section 180(1)(c), 185 and 186 of the Companies Act, 2013 7. any other business
- BSE India
- 2 days 9 hours ago
Pursuant to Regulation 32 of the SEBI(LODR) Regulation, 2015 Read with SEBI circular dated 24th December, 2019 regarding the submission of the statement of deviation or variation from the proceeds of public issue/rights issue/preferential issue, qualified institutional placement etc. we hereby confirm that the company has not raised any further funds by means of Public Issue, rights issue or preferential issue etc. hence the statement of deviation and variation is not applicable to the company.
- BSE India
- 6 days 15 hours ago
in the terms of Regulation 47 of the SEBI(LODR) Regulation, 2015 Please find the copy of the Newspaper in the English and vernacular Language of the State, wherein the Unaudited Standalone and Consolidated Financial Statements for the Quarter Ended on June 30, 2026 Published.
- BSE India
- 6 days 15 hours ago
Vivanza Biosciences Financials
Vivanza Biosciences Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹1.90
- 50 Day
- ₹1.90
- 100 Day
- ₹1.90
- 200 Day
- ₹2.00
Resistance and Support
- R3 2.20
- R2 2.10
- R1 2.00
- S1 1.70
- S2 1.60
- S3 1.50
Vivanza Biosciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-17 | Others | |
| 2026-08-07 | Quarterly Results | (Revised) |
| 2026-06-18 | Others | Inter-alia, to consider 1. Approve appointment of Mr. Hemant Amrish Parikh as a Non-Executive Non-Independent Director. 2. Approve the transfer of certain unverified shares. 3. Other business matters. |
| 2026-05-07 | Audited Results | (Revised) |
| 2026-02-12 | Quarterly Results |
About Vivanza Biosciences
Vivanza Biosciences is engaged in the business of Pharmaceutical Products. View More- NSE Symbol
- VIVANZA
- BSE Symbol
- 530057
- ISIN
- INE984E01035
Similar Stocks to Vivanza Biosciences
Popular Stocks
Vivanza Biosciences FAQs
Vivanza Biosciences share price is ₹1 As on 15 August, 2026 | 02:55
The Market Cap of Vivanza Biosciences is ₹7.6 Cr As on 15 August, 2026 | 02:55
The P/E ratio of Vivanza Biosciences is 16.7 As on 15 August, 2026 | 02:55
The PB ratio of Vivanza Biosciences is 1.7 As on 15 August, 2026 | 02:55
The 52 week High & Low of Vivanza Biosciences is ₹2.7/₹1.5 respectively As on 15 August, 2026 | 02:55
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.